An expert in equitable healthcare delivery, MIH CEO Lisa Sloane will advise on Ohio’s vaccination efforts as a member of the Ohio Department of Health’s COVID-19 Minority Health Vaccine Workgroup.

Health equity champion Lisa Sloane, MHA, Founder and CEO of MIH, will be teaching and advising for the Master of Health Administration program in the College of Public Health at The Ohio State University.

An intensive care nurse at Northwell Health’s Long Island Jewish Medical Center in Queens, NYC is the first to receive the Pfizer-BioNTech COVID-19 vaccine authorized for emergency use.

In this podcast, MIH founder Lisa Sloane discusses how she led her company to respond to the effects of the pandemic while helping clients rise to the challenge of a rapidly evolving social landscape.

Healthcare providers and data analysts from MIH client Massachusetts General Brigham Health System explain the importance of examining COVID-19-related illness, hospitalizations, and deaths grouped by demographic data to identify and address racial disparities.

MIH founder Lisa Sloane weighs in on why diverse populations might hear, trust, and respond differently to public health concerns, and how authorities could communicate more effectively and inclusively during the COVID-19 crisis.

MIH founder Lisa Sloane is interviewed about her work improving healthcare delivery and discusses how female-identifying entrepreneurs can establish credibility and stay true to themselves at tables where they may not be invited to sit.

In this bylined piece, MIH founder Lisa Sloane addresses the importance of equity within the healthcare delivery system, and the need to embrace it from the very top down.